THE Department of Health (DOH) on Monday said the recent spike in hand, foot, and mouth disease (HFMD) cases does not imply a dangerous outbreak but is a result of improved case reporting.
“We cannot call this an outbreak,” said DOH Assistant Secretary Albert Domingo, explaining that 94 percent of the logged cases are still considered “suspect” and are not yet laboratory-confirmed.
Rise in HFMD cases due to better reporting, not outbreak
As of Aug. 9, the latest DOH data showed HFMD cases reaching 37,368 — over seven times higher than the 5,081 cases during the same period last year.
Despite the increase, Domingo emphasized that HFMD is not fatal and usually resolves within 7 to 10 days.

Rise in HFMD cases due to better reporting, not outbreak
But DOH urged the public to remain cautious, especially during the wet season when transmission of the viral infection is more likely., This news data comes from:http://kxt-nh-yu-hu.erlvyiwan.com
HFMD spreads through saliva, respiratory droplets, and contaminated surfaces.
Symptoms include fever, sore throat, rashes, and painful sores on the hands, feet, and inside the mouth.
In an earlier report, Health Secretary Ted Herbosa noted that the disease is highly contagious among children, because they spend more time indoors in the rainy season, making transmission easier.
While there is no specific cure, supportive treatment such as hydration, rest, and fever reducers can help patients recover faster.
- House suspends DPWH budget deliberations pending submission of changes by agency, DBM
- Customs recovers 10 more Discaya luxury cars
- Emma Tiglao crowned Miss Grand PH 2025
- Taiwan: China illegally deploying oil rigs in its waters
- More funding sought for sports commission
- Metro Manila disaster agencies expand response areas in preparation for 'Big One'
- DPWH engineer denies role in Bulacan flood control ‘ghost projects’
- Construction managers, developers back Housing chief's anti-corruption advocacy
- DOTr denies ordering shutdown of online selling platforms
- Trump plans a hefty tax on imported drugs, risking higher prices and shortages